Wayne Gordon, executive director of commodities at UBS Global Wealth Management, says he expects gold prices to hit $2,850 ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

Shell ( NYSE: SHEL) -2.5% in Wednesday's trading following its disappointing Q4 update, but UBS nevertheless upgrades shares ...

UBS Securities on Wednesday upgraded PulteGroup (NYSE:PHM) stock to Buy from Neutral, highlighting promising margins, while ...

Nicolas Gaudois, head of Asia-Pacific technology research at UBS, discusses the main growth drivers for the names under its ...

UBS analysts upgrade Bank of America (BAC) to Buy from Neutral and lift their price target to $53 from $43. The analysts ...

Authorities entered impeached President Yoon Suk Yeol's compound, evading a crowd of protesters outside, but were confronted ...

UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss ...

UBS claims that although the larger market had a considerably lesser gain of 5.0%, the Big 6 saw profits rise of 38.9% in ...

Chinese stock investors should “stay on the defensive side” as consumption remains weak and volatility is expected to rise ...

UBS analyst Joshua Stone upgraded Shell (SHEL) to Buy from Neutral with a price target of 3,000 GBp, up from 2,800 GBp. Shell now has the ...

UBS raised the firm’s price target on United Therapeutics (UTHR) to $475 from $415 and keeps a Buy rating on the shares as part of a broader ...